Bausch Health Americas, Inc.

This study tests whether a new form of the drug rifaximin can delay the first episode of overt hepatic encephalopathy (a serious brain complication) in people with liver cirrhosis who also have fluid buildup in the belly (ascites). About 466 adults will receive either the drug or…

This study planned to test the safety and effectiveness of an inhaled drug called Virazole (ribavirin) in adults hospitalized with COVID-19 who had serious breathing trouble. The trial was withdrawn before enrolling any participants, so no results are available. It was a very ear…

This Canadian study follows about 394 adults with plaque psoriasis who are starting brodalumab as part of their regular care. Over 12 months, researchers measure changes in skin-related quality of life, work productivity, and treatment satisfaction. The goal is to understand how …

This study tests a next-generation Fraxel laser on 49 adults aged 21-60 with sun damage, skin lesions, or wrinkles around the eyes. Participants get 3 laser treatments, and doctors check if their skin looks better. The goal is to see if the laser is safe and effective for improvi…

This Canadian study follows about 200 people aged 12 and older with acne who use a prescription gel containing three active ingredients. Researchers want to see how satisfied patients are, how well they stick to the treatment, and how safe and effective it is over 20 weeks. Parti…

This study looks at how safe and tolerable a single dose of brodalumab is for children aged 6 to under 18 with severe plaque psoriasis. It also measures how the drug moves through their bodies. Only 2 children are enrolled, and the main goal is to check the drug's peak level in t…

This study watches adults with moderate-to-severe psoriasis who are already taking brodalumab or other psoriasis treatments to see how safe they are over time. Researchers will track cancer rates and other side effects. No new drugs are given—just observation of real-world care.…

This study follows 8,000 children aged 2 to 17 with eczema who have used Elidel cream. Researchers want to see if the cream increases the risk of cancer over 10 years. No new treatment is given—this is an observational study to gather safety information.